Loading organizations...
The Pill Club operates as a telemedicine platform providing women's healthcare services, primarily focusing on the delivery of birth control, but also offering skincare and menstrual care products directly to patients. It integrates online consultations with licensed medical providers to manage prescriptions and ensures discreet, convenient delivery, simplifying access to essential health products.
Founded in 2014 by Nicholas Chang and Kevin Chung, The Pill Club emerged from an insight into the inefficiencies women faced in accessing routine reproductive and dermatological care. Chang and Chung sought to leverage technology to streamline this process, removing barriers like appointment scheduling and pharmacy trips, making crucial healthcare services more accessible and user-friendly.
The platform serves women across various demographics, particularly those prioritizing privacy, convenience, and affordability in managing their reproductive and skin health needs. The Pill Club envisions empowering women with effortless control over their healthcare decisions, ensuring essential medical services and products are readily available and seamlessly integrated into their daily lives.
The Pill Club has raised $101.0M across 3 funding rounds.
The Pill Club has raised $101.0M in total across 3 funding rounds.
The Pill Club has raised $101.0M in total across 3 funding rounds.
The Pill Club's investors include Base10 Partners, Daffy, Arash Ferdowsi, Dylan Field, Dara Khosrowshahi, George Ruan, ACME, Google Ventures, iGlobe, Shasta Ventures, VMG Partners, Aleph VC.
# The Pill Club: A Digital Health Pioneer in Women's Healthcare
The Pill Club is a telehealth company that democratizes access to women's healthcare through direct-to-consumer delivery and telemedicine services[1][2]. Founded in 2014, the company has evolved from a birth control delivery platform into a comprehensive digital health service addressing reproductive care, skincare, and menstrual health[1][2]. The company rebranded as Favor in March 2023 to reflect this broader mission[1][4].
The platform serves a critical gap in the healthcare system by offering affordable, accessible care to women and people who menstruate across all 50 states, accepting Medicaid, major insurance plans, and cash payments[4]. With backing from Stanford physicians and support from prominent venture investors, The Pill Club has raised $118.49 million in total funding and treated nearly 1 million patients before its asset sale to Thirty Madison in April 2023[2].
The Pill Club was founded in 2014 and launched commercially in 2016 in San Carlos, California[5]. The company emerged from founder and CEO Nick Chang's prior entrepreneurial experience with Ganogen, a healthcare startup focused on organ donor access that ultimately shut down[5]. Chang, who holds an M.D. from Duke University, channeled those learnings into The Pill Club's mission to remove barriers to reproductive healthcare[5].
The company gained early traction through backing from prominent incubators including StartX and 500 Startups, and secured significant venture validation with a $51 million Series B round in 2019 led by VMG Partners, with participation from GV and ACME Capital[5]. By 2019, the company had assembled a 260-person team and was operating its own pharmacy licensed to prescribe in 35 states[5].
The Pill Club exemplifies the convergence of fintech, healthcare, and consumer technology—using direct-to-consumer distribution and telemedicine to disrupt traditionally gatekept healthcare services[5]. The company rides several powerful trends: growing venture capital interest in women's health technology, increasing consumer comfort with telehealth post-pandemic, and societal momentum around reproductive autonomy and healthcare access[5].
The timing has been particularly favorable for The Pill Club's model. Regulatory barriers to telemedicine have lowered, consumer demand for privacy-respecting healthcare has grown, and venture investors have increasingly recognized women's health as an underserved market segment[5]. By accepting insurance and Medicaid alongside cash payments, The Pill Club positioned itself as a bridge between traditional healthcare and direct-to-consumer innovation—a model that influences how other health startups think about accessibility and payment flexibility.
The Pill Club's transition to Favor reflects a maturing company recognizing that birth control delivery alone was insufficient for long-term growth. The April 2023 asset sale to Thirty Madison—which acquired the company's patient base and strategic assets—suggests the company pivoted from independent operation toward integration within a larger telehealth ecosystem[2].
Looking forward, the broader women's health tech sector will likely continue consolidating around platforms that can offer integrated services (reproductive health, skincare, mental health) while maintaining affordability and accessibility. The Pill Club's legacy influence lies in proving that consumer-friendly, insurance-agnostic telehealth models can achieve scale in healthcare—a lesson that shapes how digital health companies approach market access today.
The Pill Club has raised $101.0M across 3 funding rounds. Most recently, it raised $42.0M Series B in June 2021.
| Date | Round | Lead Investors | Other Investors | Status |
|---|---|---|---|---|
| Jun 1, 2021 | $42M Series B | Base10 Partners | Daffy, Arash Ferdowsi, Dylan Field, Dara Khosrowshahi, George Ruan, Acme, GV, Iglobe, Shasta Ventures, VMG Partners | Announced |
| Jan 1, 2019 | $51M Series B | VMG Partners | Aleph VC, Amity Ventures, TJ Nahigian, Base10 Partners, Battery Ventures, Canvas Ventures, Catapult Capital, Citi Ventures, Cleo Capital, Footwork, Frederique Dame, GV, Hillsven Capital, Norwest Venture Partners, Olima Ventures, OurCrowd, Piva Capital, Recursive Ventures, SignalFire, The HIT Forge, Tribeca Venture Partners, UpWest, Clark Landry, Curtis LEE, Evan Williams, George Ruan, Jake Zeller, Jonathan Swanson, Michael Birch, Michael Stoppelman, Oliver Thylmann, ACME Capital, Shasta Ventures | Announced |
| Feb 1, 2018 | $8M Series A | — | Amity Ventures, Base10 Partners, Canvas Ventures, Cleo Capital, Olima Ventures, Piva Capital, Jake Zeller, Jonathan Swanson, Michael Stoppelman | Announced |